Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
pharmaceutical manufacturers in Europe:
GlaxoSmithKline plc
of the United Kingdom
(2012
sales of £26.43 billion [US$40.11 billion]
of which 81%
was Pharmaceuticals),
Bayer AG
of Germany
(39.76 billion Euro [US$51.04 billion]
of which 29%
was Material Science), and
Sanofi S.A.
which is
based in France
(34.95 billion Euro [US$44.86 billion]
of which 83%
was Pharmaceuticals).
Sales Analysis.
Roche Holding Aktiengesellschaft reported sales of 45.50 billion Swiss Francs (US$46.81 billion)
for the
year ending
December of 2012.
This
represents
an
increase of 7.0%
versus 2011, when the company's sales were 42.53 billion Swiss Francs.
Despite this increase, sales are still
below the level achieved in 2010, when Roche Holding Aktiengesellschaft
reported sales of 47.47 billion Swiss Francs.
The sales level in 2012 was fairly close to the level five years ago: in 2007, Roche Holding Aktiengesellschaft had sales
of 46.13 billion Swiss Francs.
Sales of Pharmaceuticals saw an increase
of
7.4% in 2012, from
32.79 billion Swiss Francs to 35.23 billion Swiss Francs.
Business Description